Venue: Holiday Inn & Suites Dubai Science Park, an IHG Hotel, Dubai, UAE.
IHG Hotel, Dubai Science Park, Dubai, UAE.
CEO & Owner
Pharsafer
Associate Director and Global Head – Pharmacovigilance
Emcure Pharmaceuticals
Global Head – PV
Alkem Laboratories
Vice President & Global Head – Pharmacovigilance
Glenmark Pharmaceuticals
PV Leader & Consultant
Deputy Site Head and
Medical Review TA Head
– Patient Safety
Bristol Myers Squibb
Technology Evangelist
Veeva Systems
Head – Pharmacovigilance
Cipla Ltd.
PharSafer is a Global CRO specialising in all aspects of Clinical & Post Marketing Safety; Medical Affairs; Regulatory Strategy; Auditing; Training; IT Informatics & Development. Established for over 20 years; PharSafer has a wealth of experienced individuals in the Company able to help clients in all areas of vigilance – from case processing to signal detection and from drugs to devices to vaccines; biologics; advanced therapies and cosmetics.
SafeVig Solutions is a forward-thinking, globally recognized organization that stands at the intersection of life sciences and cutting-edge technology, offering specialized solutions to pharmaceutical and biotechnology companies. With a primary focus on advancing pharmacovigilance, SafeVig leverages a robust combination of Automation, Artificial Intelligence (AI), Machine Learning (ML), and Blockchain to transform operational processes and resolve functional challenges within the industry.
Since its inception, SafeVig has continually evolved its suite of services and technologies, enabling organizations to move beyond traditional compliance-based models and take full ownership of patient safety.
SafeVig’s comprehensive solutions not only streamline and enhance pharmacovigilance operations but also bring exponential improvements in efficiency, achieving up to a 10X increase through the intelligent use of technology. With an unwavering commitment to synergy, quality, and innovation, SafeVig Solutions has become a trusted partner for global organizations, empowering them to adapt to regulatory demands with speed, accuracy, and enhanced safety oversight.
By partnering with us, you can position your brand at the forefront of the pharmaceutical landscape and gain invaluable exposure to a highly targeted and influential audience.
Partnering with the Drug Safety Symposium is a strategic investment, to explore partnership opportunities and discuss customized packages, please contact us at suryansh@eminencemedia.in
Gateway of India
Juhu Beach
Prithvi Cafe
Jehangir Art Gallery
Marine Drive
Siddhivinayak Temple
Haji Ali Dargah
Mount Mary Church
Elephanta Caves
Kanheri Caves
Dr. Graeme Ladds has been involved in Drug Safety for the last 35 years holding senior positions in a number of top ten Pharma. As CEO of PharSafer Graeme has established a global Company looking after the safety of many different client product types and has overseen over 100 Regulatory Inspections globally, and understands intimately the requirements for operating a compliant safety system in order to protect patients properly and quickly satisfying the regulations.
Bringing over 21 years of experience across pharmacovigilance, clinical research, and medical practice, Dr. Neha Vala is a trained medical professional with strong grounding in clinical pharmacology, GCP, and global PV guidelines, she has end-to-end expertise in risk management planning, signal management, and benefit–risk evaluation. Dr. Vala has successfully established and scaled pharmacovigilance functions for multiple organisations and has led numerous regulatory inspections, including USFDA, MHRA, EU authorities, Health Canada, and DCGI. She is also an active speaker at national and international pharmacovigilance forums.
I have been with Alkem Laboratories Ltd, Mumbai, for the past 13 years in various roles and am currently serving as the Head of Global Pharmacovigilance.
With 25 years of experience spanning both academic and industrial roles, I have played a key role in establishing an in-house Pharmacovigilance department that adheres to stringent regulatory standards and processes. This has supported our global pharmacovigilance operations through the development and implementation of comprehensive safety monitoring systems, risk management plans, and regulatory compliance strategies.
In the past five years, I have successfully led my team through three major regulatory inspections for Pharmacovigilance by the USFDA, TGA-Australia, and MoH-Kazakhstan. These inspections required meticulous preparation and a deep understanding of regulatory requirements, affirming the robustness and effectiveness of our pharmacovigilance practice
Rajendra Kasi is a healthcare professional with more than 2 decades of experience in clinical and drug safety arenas. He is the Vice-president and Global Head of Pharmacovigilance at Glenmark Pharmaceuticals Ltd. Before joining Glenmark, he worked with reputed pharmaceutical companies like Zydus Cadila and Mylan Laboratories, etc. He was pivotal in establishing Pharmacovigilance units from scratch to hatch level for major pharmaceutical players in India. He believes quality consciousness, keeping oneself up-to-date with the latest happenings in the industry, and embracing and adopting new technologies in the domain are the key factors to ensure regulatory compliance.
Dr. Siva is a physician with an MBA and holds a Lean Six Sigma Green Belt. He heads the signal and risk management along with Gen AI for safety. He has led various automation initiatives using RPA, AI, and GenAI for diverse use cases. His expertise encompasses the full range of pharmacovigilance activities, from case processing to risk management. Throughout his career, he has collaborated with numerous CROs and leading pharmaceutical firms, including Viatris and Teva Pharmaceuticals. He serves on the Board of Studies at Chitkara University, where he contributes to curriculum development and delivers guest lectures. Dr. Siva is on the Advisory Boards of GAADs, PharmaNow, and PharmaFocus Asia & EU. Furthermore, he mentors FFE scholarship recipients and acts as a medical assessor for Arogya World.
Dr. Vikram K is the Deputy Site Head and Medical Review TA Head – Patient Safety at Bristol Myers Squibb, based in Hyderabad. With over 20 years of experience across hospitals, pharma, CROs, and BPOs, he has built and mentored high-performing pharmacovigilance teams while ensuring compliance with global regulatory standards. His expertise spans medical review, large-scale study oversight, and inspection readiness, having successfully led multiple audits including USFDA, MHRA, and SwissMedic. Prior to this, he was with Eli Lilly, driving medical review capabilities. Vikram holds an MBBS, a Diploma in Diabetology, an MBA from ISB, and certifications from IIM-A and Johns Hopkins.
Umesh Khadela is a seasoned enterprise technology advisor with over 10 years of experience helping global Life Sciences organizations evaluate, select, and implement digital transformation and enterprise software solutions. Over the years, he has worked closely with senior executives across Quality, Regulatory, and R&D functions, helping them navigate complex technology adoption challenges, drive organizational alignment, and achieve measurable business outcomes.
He specializes in bridging business and technology conversations by enabling leadership teams to define the right transformation strategy, establish meaningful success KPIs, and accelerate value realization from enterprise platforms and digital initiatives.
Dr. Prasad Deshmukh leads Global Pharmacovigilance (PV) operations at Cipla Ltd., overseeing PV activities across all regions. His role focuses on establishing and strengthening regional PV systems and fostering collaboration with cross-functional stakeholders to ensure compliance and operational excellence.
With over two decades of experience in pharmacovigilance and project management, Dr. Deshmukh brings a rich blend of clinical practice and industry expertise, having worked with BPOs, CROs, and pharmaceutical companies. His global exposure includes significant contributions to PV initiatives in regions such as Japan and China.
Throughout his career, he has successfully led cross-functional teams to implement and deliver complex PV projects. A passionate learner and mentor, Dr. Deshmukh is deeply committed to coaching and professional development. Outside of work, he enjoys reading and following sports.
